Long Term Efficacy and Safety of Orlistat for Type 1 Hyperlipoproteinemia

Condition:   Type 1 Hyperlipoprotenemia Interventions:   Drug: Orlistat;   Drug: Placebo Sponsor:   University of Texas Southwestern Medical Center Not yet recruiting

Source: ClinicalTrials.gov - April 18, 2023 Category: Research Source Type: clinical trials